A phase I/II study of VB-210 for Fibromyalgia
Latest Information Update: 28 Sep 2022
At a glance
- Drugs VB 210 (Primary)
- Indications Fibromyalgia
- Focus Adverse reactions; Therapeutic Use
- 04 Aug 2016 New trial record
Latest Information Update: 28 Sep 2022